Published in Cancer Weekly, February 5th, 2002
Studies on sulforaphane (SGS) in human cell lines and laboratory animals show its potential effect on hypertension, prostate cancer, and macular degeneration.
The studies, reported in late 2001 by scientists from Johns Hopkins, Stanford University, and the University of Saskatchewan, give new significance to the potential health benefits of sulforaphane, the antioxidant phytochemical originally isolated from broccoli, and now available to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2002-02-05)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.